Amneal Pharmaceuticals
AMRX
21.12
-0.27
-1.26%
Amneal Pharmaceuticals
US · AMRX
#1854 by market cap
Listed 1970
21.12
-0.27
-1.26%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
Quant vs Street three independent views, side by side
StockVane factor grade
C
Momentum strategy signal
Hold
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Analyst consensus 5 analysts
Buy
Avg price target 24.40 +15.5%
Price target rangecurrent 21.12
Low20.00
Avg24.40
High28.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-09 | UBS | -- | Buy | 28.00 |
| 2026-11-06 | UBS | -- | Buy | 28.00 |
| 2026-11-05 | Leerink Partners | -- | Buy | 25.00 |
| 2026-11-04 | J.P. Morgan | -- | Buy | 25.00 |
| 2026-10-29 | Goldman Sachs | -- | Buy | 24.00 |
| 2026-10-22 | J.P. Morgan | -- | Buy | 24.00 |
| 2026-09-23 | Oppenheimer | -- | Buy | 27.00 |
| 2026-09-21 | Barclays | -- | Buy | 20.00 |
| 2026-09-21 | J.P. Morgan | -- | Buy | -- |
| 2026-09-17 | Leerink Partners | -- | Buy | 23.00 |
| 2026-09-16 | Barclays | -- | Buy | 20.00 |
| 2026-09-09 | Leerink Partners | -- | Buy | 23.00 |
| 2026-08-26 | J.P. Morgan | -- | Buy | 22.00 |
| 2026-08-10 | Goldman Sachs | -- | Buy | 21.00 |
| 2026-08-03 | UBS | -- | Buy | 25.00 |
| 2026-07-15 | UBS | -- | Buy | 23.00 |
| 2026-06-11 | UBS | -- | Buy | -- |
| 2026-06-11 | Barclays | -- | Buy | 16.00 |
| 2026-06-04 | Piper Sandler | -- | Buy | 17.00 |
| 2026-05-26 | Piper Sandler | -- | Buy | 17.00 |
| 2026-05-20 | Barclays | -- | Buy | 16.00 |
| 2026-04-23 | Truist Financial | -- | Buy | -- |
| 2026-04-17 | UBS | -- | Buy | 19.00 |
| 2026-04-16 | UBS | -- | Buy | 19.00 |
| 2026-03-18 | Barclays | -- | Buy | 15.00 |
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-11-03 | -- | ±13.81% | -1.13% (in line) |
| 2026/Q2 | 2026-07-30 | -- | ±15.06% | -3.14% (in line) |
| 2026/Q1 | 2026-05-01 | -- | ±15.15% | -0.31% (in line) |
| 2025/Q4 | 2026-02-27 | -- | ±14.84% | -4.69% (in line) |
| 2025/Q3 | 2025-10-30 | -- | ±12.46% | -4.12% (in line) |
| 2025/Q2 | 2025-08-05 | -- | ±14.20% | +2.14% (in line) |
| 2025/Q1 | 2025-05-02 | -- | ±14.34% | +2.97% (in line) |
| 2024/Q4 | 2025-02-28 | -- | ±24.95% | +3.46% (in line) |
| 2024/Q3 | 2024-11-08 | -- | ±12.78% | +1.39% (in line) |
| 2024/Q2 | 2024-08-09 | -- | ±15.59% | -1.54% (in line) |
| 2024/Q1 | 2024-05-03 | -- | ±24.96% | +8.86% (in line) |
| 2023/Q3 | 2023-11-07 | -- | ±31.35% | +2.38% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 20:02:15 · For reference only, not investment advice and not tailored to your situation.
Amneal Pharmaceuticals discussion 0 comments